|
Pharmaceutical & Biotech Patent Litigation Strategies 2009 Pharma Conference intends to address the constantly evolving legal trends within the EU and US. The 3rd Annual Pharmaceutical & Biotech Patent Litigation Strategies conference is being organized by Pharma IQ, a division of IQPC. The event will offer opportunities to hear from in-house counsel, external lawyers, the European Commission, as well as leading judges within the patent litigation arena. With an alarming increase in the number of litigation cases within the Pharmaceutical and Biotech industry, the event will be helpful for the delegates to learn information and strategies to protect their market share and maximise product revenue by formulating and executing a strong yet flexible litigation strategy.
The 3rd Annual Pharmaceutical & Biotech Patent Litigation Strategies 2009 Pharma Conference will highlight many key issues, such as:
• Litigation Trends And Challenges: The International Pharmaceutical And Biotech Industry
• The European Commission’s Pharmaceutical Sector Inquiry
• The Changing Landscape Of US Anti-Competition Laws For The Pharmaceutical Industry
• The Emerging Challenges Linked With Anti- Trust Laws In Patent Litigation And Settlements
• The Evolving Face Of Inventive Step In Europe
• Identifying And Overcoming Issues When Planning And Formulating An Effective Patent Litigation Strategy
• Co-Ordinating Patent Litigation: The Role Of The Netherlands
• Understanding The Evolving IP Landscape In India And It’s Effect On Pharmaceutical Patent Litigation
• The View From The Other Side Of The Fence: The Generic Company Approach
• Innovator Company Counter-Strategies When Patents Are Contested
• The Role Of Lifecycle Management In Patent Litigation
Organizer
IQPC